NEW YORK – Which articles gained the most attention from GenomeWeb's readers last week? Here are the top five:
- Debate Over Multi-Cancer Screening Tests Shifts Pending Grail Randomized Trial Results
- Eric Green's Term as NHGRI Director Ends as Appointment Not Renewed by NIH
- Cepheid to Lay off 167 Employees
- Genomic Screening Uncovers Actionable Results in Thousands of Exome-Sequenced MyCode Participants
- Pharma, Dx Leaders Urge MRD Community to Focus on Clinical Utility as Use in Trials Grows